Navigation Links
Pharmaceutical use in Norwegian fish farming in 2001-2007
Date:4/28/2008

The Norwegian Institute of Public Health has published an overview of sales of various drugs used in fish breeding in Norway from 2001-2007. The sales are shown in kilograms of active ingredient; antibacterials, anaesthetics, anthelmintics and treatments for sea lice and fungi. The figures are based on sales from wholesalers to pharmacies and from feed mills to breeders.

After an increase in sales of antibacterials from 2002-2006, sales in 2007 returned to levels seen in 2001. Prescription-based statistics from the Norwegian Food Safety Authority for the period 2000-2006 show that this increase can be blamed on new breeding species, especially cod. However, the increase in use for cod was positively correlated to the increase in biomass cod produced.

For more detailed data, including tables of information view the full news article on the NIPH's website located at http://www.fhi.no/eway/default.aspx?pid=238&trg=Area_5954&MainLeft_5812=5954:0:&Area_5954=5825:68486::0:5955:1:::0:0.


'/>"/>

Contact: Media Contact
info@fhi.no
Norwegian Institute of Public Health
Source:Eurekalert

1

GOOD

Page: 1

Related biology news :

1. Pharmaceutical breakthrough may make a range of drugs cheaper and more available
2. Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design
3. NMR researchers unlock hydrogens secrets to spot polymorphism in pharmaceuticals
4. Biopharmaceutical infrastructure key to lower drug development costs
5. Researchers develop liquid crystal pharmaceuticals to fight cancer and other diseases
6. Bacteria from sponges make new pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., The DFG has approved the establishment of 17...y 2010. This decision was made recently by the rel...ll initially be funded for four years with a total...funding for indirect costs will also be provided f...e from modern prostheses to political reforms to m...
(Date:11/30/2009)...l Biology are pleased to announce that Dr Xavier ...ifique (CNRS) in the Universit de Nice-Sophia-Anti...ng Paper Prize. ,The prize is awarded in recogniti...o encourage young scientists, says Hans Hoppleler...ly appreciate when authors submit their very best ...
(Date:11/30/2009)...ientists are presented with the complex challenge ... a paper published in Insect Conservation and Div...uel Rodriguez assess this challenge. , Twentieth...C has already affected the Earth,s biota and now t...ary biologists is to predict how biological impact...
Breaking Biology News(10 mins):DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4How can scientists measure evolutionary responses to climate change? 2Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 1Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 2Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 3Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 4Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 5Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 6Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 7Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 8Guardian Provides 100 25 Coverage For Swine Flu Vaccine 59321 1Guardian Provides 100 25 Coverage For Swine Flu Vaccine 59321 2Regence Video Asks What if Everything Worked Like Health Care 3F 59316 1Regence Video Asks What if Everything Worked Like Health Care 3F 59316 2Regence Video Asks What if Everything Worked Like Health Care 3F 59316 3
...te is partly genetic, according to a new study pub...The research, by James H. Fowler and Christopher T...o and Laura A. Baker, of the University of Souther...uence participation in elections and in a wide ran...: http://www.apsanet.org/imgtest/APSRMay08Fowler_...
...guins makes these iconic swimming and diving seabi...le to environmental changes. Pronounced warming in...ing, and oil and gas development at lower latitude...to P. Dee Boersma, of the University of Washington...Science, Boersma provides a first-person account ...
... light effects the growth and development of plant...nimals? A new paper by Nathalie Hoang et al., publ...uestion by examining cryptochromes in flies, mice,...eptor proteins which absorb and process blue light...t, and leaf and stem expansion. Cryptochromes are ...
Other Biology News:Political participation is partially rooted in genetic inheritance 2Political participation is partially rooted in genetic inheritance 3A mammalian clock protein responds directly to light 2
(Date:12/1/2009)... Enterprise level storage is now availabl...without breaking the bank. , ... www.pacsdrive.com ), a medical imaging software ...atible cloud storage service. The PacsDrive servic...ders to securely archive medical imaging in compli...
(Date:12/1/2009)...BURY, N.J., Dec. 1 Palat...ounced that the U.S. Patent and Trademark Office h...c Natriuretic Peptide Constructs." The claims in ...ds that bind to natriuretic peptide receptor A (NP...re drug candidate. ,, "Our natriuretic compound...
(Date:12/1/2009)...IANAPOLIS and NORTH VANCOUVER, British Columbia, D...LC, a wholly owned subsidiary of The Dow Chemical ...Inc. today announced the signing of a research and...t provides Dow AgroSciences with access to Agrisom...logy on an exclusive basis in major food crops, an...
(Date:12/1/2009)...ORK and MONTREAL, Dec. 1 /PRNewswire-FirstCall/ - ...td. (OTCPK: ICBT), announced today that the compan...ng Inc., of Canada for the manufacturing of the TO...n the U.S. ,, "We have seen the disastrous resu...ables and packaged salads in the past" said Don Sa...
Breaking Biology Technology:PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3
...colys BioPharma,Inc. (Tokyo, Japan) and Tacere The...y that they have entered into a strategic alliance...e throughout Asia, Tacere,s,RNA interference (RNAi...ode-named by Oncolys as OBP-701. This agreement re... Tacere and Oncolys in June 2007, whereby,Oncolys ...
...(NYSE:,AZN) announced today that it has completed ...s for vandetanib, the company,s investigational,on...e treatment of,non-small cell lung cancer (NSCLC).... with Docetaxel In non-smAll cell lung Cancer) and...) -- are the second and third of four,ongoing stud...
...Health, Inc. (Nasdaq: GHDX ) today announced that...Chief Executive Officer, will present at the,Lehma...rence in Miami, FL,on March 19, 2008 at 5:15 p.m. ...y archived webcast of the,presentation, visit the ...site at http://investor.genomichealth.com . Pleas...
Other Biology Technology:Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 2Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 3AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC) 2AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC) 3Genomic Health to Present at Lehman Brothers Global Healthcare Conference 2
Reacti-Bind Maleic Anhydride Activated Polystyrene 96-Well plates from Pierce Biotechnology, Inc.
Cleanascite HC 500 from Biotech Support Group
Slide Moat Microscope Slide Incubator from Sigma-Aldrich
Lyophilization Stabilizer from GenScript Corporation
Biology Products: